Results 201 to 210 of about 104,869 (316)
Neuroimmune-Lipid Crosstalk in Chronic Itch: Molecular Mechanisms from Skin Surface to Cerebral Cortex. [PDF]
Kim HB +5 more
europepmc +1 more source
ABSTRACT Molluscum contagiosum (MC) is a common viral skin infection in children. In the two Phase 3 Cantharidin Application in Molluscum Patients [CAMP‐1 and CAMP‐2] studies, cantharidin, a drug‐device combination containing cantharidin (0.7%), a topical vesicant, was significantly superior to placebo in achieving complete clearance of MC lesions at ...
Takafumi Kadono +9 more
wiley +1 more source
Short-Term Cost per Responder of Lebrikizumab versus Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Model-Based Payer Analysis. [PDF]
Almutlaq H.
europepmc +1 more source
ABSTRACT Atopic dermatitis (AD), a prevalent inflammatory skin disease, significantly impairs quality of life. Pruritus manifests variably, complicating its classification and management. This study analyzed real‐world, self‐reported data from Atopiyo, Japan's largest AD smartphone application (October 2021–October 2024), to explore itch patterns ...
Atsushi Otsuka +7 more
wiley +1 more source
Itch Is Now Made Visible: Advances in fMRI and Its Relevance to Dermatology. [PDF]
Schandua H +6 more
europepmc +1 more source
ABSTRACT Vunakizumab is a humanized anti‐IL‐17A monoclonal antibody approved in China for moderate‐to‐severe plaque psoriasis. Real‐world data on its effectiveness and predictors of response remain scarce. This prospective, single‐center, observational study enrolled 34 adults receiving vunakizumab (240 mg subcutaneously at weeks 0, 2, and 4, then ...
Tong Wu +4 more
wiley +1 more source
This case note critically examines the January 2026 High Court judgment in The King (on the application of The Howard League for Penal Reform) v The Secretary of State for Justice which dismissed a judicial review challenging the expansion of the use of PAVA spray in Young Offender Institutions (YOIs) in England.
Raymond Arthur
wiley +1 more source
JAK1 Inhibitors for Eczematous Eruptions Following Anti-IL-17A Therapy in Psoriasis: A Case Series. [PDF]
Zhang L +5 more
europepmc +1 more source
Abstract Background and aims Globally, around 11% of adolescents aged 13–15 years use tobacco products, and over one‐third of users are estimated to be tobacco dependent. Interventions to support adolescents to quit smoking are recommended to mitigate adverse health effects.
Courtney Barnes +12 more
wiley +1 more source

